If you would start a 200-person challenge trial I would expect the FDA suddenly to care a lot because that’s actually a challenge to the way they regulate drugs.
If you would start a 200-person challenge trial I would expect the FDA suddenly to care a lot because that’s actually a challenge to the way they regulate drugs.